Cat.#: ASSD-119
| Description | A fluorescent adenosine receptor ligand derived from NECA, non-selective adenosine agonist. Fluorescent adenosine receptor agonist (pEC50 values are 8.57, 8.47, 6.76 and 5.69 for A3, A1, A2A and A2B respectively). |
| Synonyms | Fluorescent Adenosine receptor Agonist (A-633-AG), A-633-AG, ABEA-X-BY630 |
| Size | 500 μg |
| Applications | For ligand binding; fluorescence imaging; high content analysis; kinetic analysis; cell sorting at adenosine A1 / A2A / A3 receptors use solutions up to 100 nM. |
| Molecule Weight | 925 |
| Purity | >97% |
| Solubility | Soluble in DMSO |
| Form | Purple solid |
| Excitation | 638 nm |
| Emission | 657 nm |
| Storage | Store at -20° C (protect from light) |
| Shipping | Shipped at 4°C |
| Important | We recommend briefly sonicating the sample when using to ensure it is fully dissolved and the solution is homogeneous. However, we do not recommend using the product after subjecting it to repetitive freeze-thaw cycles. |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ASSD-205 | Acridinium C2 NHS Ester (AC205) | 5 mg, 10 mg | inquiry |
| ASSD-128 | Fluorescent M3 antagonist [pirenzepine] (AC128) | 50 μg | inquiry |
| ASSD-187 | Quinaldine Red (AC187) | 5 g, 25 g, 100 g, 250 g | inquiry |
| ASSD-169 | Calcium Ionophore A23187 (AC169) | 1mg, 5mg, 10 mg | inquiry |
| ASSD-154 | Brilliant Blue R-250 (AC154) | 1g, 5g | inquiry |
| ASSD-192 | 4-Fluoro-7-nitrobenzofurazan (AC192) | 5 mg, 25 mg, 50 mg | inquiry |
| ASSD-213 | Fluorescein 6-Maleimide (AC213) | 25 mg, 250 mg | inquiry |
| ASSD-212 | 5(6)-Carboxy-2′,7′-dichlorofluorescein diacetate N-succinimidyl ester (AC212) | 25 mg | inquiry |
| ASSD-222 | Antifade Fluorescence Mounting Medium with Propidium Iodide (hard set) (AC222) | 10 mL | inquiry |
| ASSD-134 | FITC Phalloidin (AC134) | 300 tests, 100μg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.